VKTX - Viking Therapeutics, Inc.

QQQ $ 589.37 $ -22.30 (-3.65 %)

DIA $ 459.88 $ -6.80 (-1.46 %)

SPY $ 656.23 $ -16.68 (-2.48 %)

TLT $ 89.22 $ 0.24 (0.26 %)

GLD $ 374.83 $ -0.35 (-0.09 %)

Previous Close

$ 36.04

Open

$ 36.96

Bid

$ 34.79 x 40

Ask

$ 34.79 x 31

Day's Range

$ 34.67 - $ 37.29

52 Week Range

$ 18.92 - $ 56.25

Volume

4,622,787

Average Volume

Market Cap

4.07B

Beta (5Y Monthly)

$ 1.57

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	10-22-2025	09-30-2025	10-Q
2	07-23-2025	06-30-2025	10-Q
3	04-24-2025	03-31-2025	10-Q
4	02-26-2025	01-01-1970	10-K
5	10-23-2024	09-30-2024	10-Q
6	07-24-2024	06-30-2024	10-Q
7	04-25-2024	03-31-2024	10-Q
8	02-07-2024	12-31-2023	10-K
9	10-25-2023	09-30-2023	10-Q
10	07-26-2023	06-30-2023	10-Q
11	04-26-2023	03-31-2023	10-Q
12	02-10-2023	12-31-2022	10-K
13	10-26-2022	09-30-2022	10-Q
14	07-27-2022	06-30-2022	10-Q
15	04-27-2022	03-31-2022	10-Q
16	02-09-2022	12-31-2021	10-K
17	11-03-2021	09-30-2021	10-Q
18	07-28-2021	06-30-2021	10-Q
19	04-28-2021	03-31-2021	10-Q
20	02-17-2021	12-31-2020	10-K
21	10-28-2020	09-30-2020	10-Q
22	07-29-2020	06-30-2020	10-Q
23	04-30-2020	03-31-2020	10-Q
24	02-26-2020	12-31-2019	10-K
25	11-05-2019	09-30-2019	10-Q
26	08-01-2019	06-30-2019	10-Q
27	05-02-2019	03-31-2019	10-Q
28	03-13-2019	12-31-2018	10-K
29	11-07-2018	09-30-2018	10-Q
30	08-09-2018	06-30-2018	10-Q
31	05-09-2018	03-31-2018	10-Q
32	03-07-2018	12-31-2017	10-K
33	11-08-2017	09-30-2017	10-Q
34	08-09-2017	06-30-2017	10-Q
35	05-10-2017	03-31-2017	10-Q
36	03-21-2017	12-31-2016	10-K
37	11-10-2016	09-30-2016	10-Q
38	08-11-2016	06-30-2016	10-Q
39	05-10-2016	03-31-2016	10-Q
40	03-08-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Viking Therapeutics Completes Enrollment A...
11/19/2025 08:23:18

78-Week Study Evaluating Subcutaneous VK2735 in Adults with ObesityEnrollment Completed Ahead of Schedule and Above Target Size...

druckenmiller-opens-position-in-amazon-closes-microsoft--heres-more-of-duquesnes-biggest-q3-moves

Druckenmiller Opens Position In Amazon, Cl...
11/14/2025 21:59:21

Stanley Druckenmiller's Duquesne Family Office Q3 13F reinforces the firm's reputation for agile and opportunity-driven...

Canaccord Genuity Maintains Buy on Viking ...
11/12/2025 13:09:48

Canaccord Genuity analyst Edward Nash maintains Viking Therapeutics (NASDAQ:VKTX) with a Buy and raises the price target fro...

amd-oklo-applovin-corp-viking-therapeutics-and-novo-nordisk-why-these-5-stocks-are-on-investors-radars-today

AMD, Oklo, AppLovin Corp, Viking Therapeut...
11/12/2025 01:31:43

Major U.S. indices closed mixed on Tuesday, with the Dow Jones Industrial Average climbing 1.2% to 47,927.96 and the S&P 50...

Viking Therapeutics Data From Phase 2 VENT...
11/06/2025 12:25:45

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the developm...

druckenmillers-viking-trade-just-hit-a-golden-cross--and-a-sweet-36-gain

Druckenmiller's Viking Trade Just Hit A Go...
11/05/2025 15:01:24

Stanley Druckenmiller's firm bought Viking Therapeutics stock (VKTX) during Q2 at $25.33. Now up 36%, VKTX shows a Golden C...

jim-cramer-says-take-a-pass-on-this-tech-stock-wont-go-near-oils

Jim Cramer Says 'Take A Pass' On This Tech...
11/05/2025 13:33:42

Zoom Communications is a good company, Cramer says. Still, he advises, "take a pass." Plus: Viking Therapeutics, Profra...

10 Health Care Stocks Whale Activity In To...
10/30/2025 17:35:24

Viking Therapeutics Announces That Its VV2...
10/29/2025 20:23:54

Poster Presentation on VENTURE Study Results Evaluating Impact of VK2735 on Prediabetes and Cardiometabolic StatusAdditional Po...

Canaccord Genuity Initiates Coverage On Vi...
10/29/2025 11:07:23

Canaccord Genuity analyst Edward Nash initiates coverage on Viking Therapeutics (NASDAQ:VKTX) with a Buy rating and announce...

JP Morgan Maintains Overweight on Viking T...
10/24/2025 13:27:25

JP Morgan analyst Hardik Parikh maintains Viking Therapeutics (NASDAQ:VKTX) with a Overweight and lowers the price target fr...

why-is-viking-therapeutics-stock-rising-today

Why Is Viking Therapeutics Stock Rising To...
10/23/2025 16:32:47

Viking Therapeutics shares are rising Thursday. The clinical-stage biopharmaceutical company reported third-quarter earnings an...

Morgan Stanley Maintains Overweight on Vik...
10/23/2025 13:14:57

Morgan Stanley analyst Michael Ulz maintains Viking Therapeutics (NASDAQ:VKTX) with a Overweight and raises the price target...

Viking Therapeutics Q3 EPS $(0.81) Misses ...
10/22/2025 20:11:36

Viking Therapeutics (NASDAQ:VKTX) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of...

Earnings Scheduled For October 22, 2025
10/22/2025 08:32:26

Earnings Preview For Viking Therapeutics
10/21/2025 18:02:12

Viking Therapeutics Initiates VK2735 Maint...
10/21/2025 11:07:14

retail-investors-top-stocks-with-earnings-this-week-tesla-netflix-intel-and-more

Retail Investors' Top Stocks With Earnings...
10/20/2025 11:53:01

Retail investors prepare for the first busy week in the Q3 earnings season, with Tesla, Netflix and Intel on deck.

HC Wainwright & Co. Reiterates Buy on Viki...
09/29/2025 14:38:29

HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ: VKTX) with a Buy and maintains $102...

6 Health Care Stocks Whale Activity In Tod...
09/22/2025 17:35:25